Kopin Amends Enveric Biosciences Stake, Maintains Significant Holding

TL;DR

**Mitchell P. Kopin updated his Enveric Biosciences stake, signaling continued interest.**

AI Summary

Mitchell P. Kopin, a member of the investment group 03 Life Sciences, filed an amended Schedule 13G/A on February 6, 2024, indicating his beneficial ownership of Enveric Biosciences, Inc. (NASDAQ: ENVB) common stock as of December 31, 2023. This filing updates previous disclosures, showing Kopin's continued significant stake in the pharmaceutical preparations company. This matters to investors because large institutional or individual holdings can influence stock stability and signal confidence (or lack thereof) in the company's future.

Why It Matters

This filing shows a key investor's updated position in Enveric Biosciences, which can influence market perception and potentially impact stock price due to the size of the holding.

Risk Assessment

Risk Level: low — This is a routine amendment to a beneficial ownership filing, indicating no immediate new risks but rather a status update.

Analyst Insight

Investors should note that a significant individual investor, Mitchell P. Kopin, continues to hold a position in Enveric Biosciences. While this filing doesn't reveal a change in ownership percentage, it confirms his ongoing stake, which could be a factor in assessing long-term investor confidence.

Key Players & Entities

• Mitchell P. Kopin (person) — Reporting Person, beneficial owner of Enveric Biosciences, Inc. common stock
• Enveric Biosciences, Inc. (company) — Subject Company, a pharmaceutical preparations company
• 03 Life Sciences (company) — Group Member associated with the filing
• INTRACOASTAL CAPITAL, LLC (company) — Filing entity associated with the reporting person

FAQ

Key Financial Figures

• $0.01 — , Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of

Filing Documents

• ea192881-13ga2intra_enveric.htm (SC 13G/A) — 75KB
• 0001213900-24-010319.txt ( ) — 77KB

Ownership

Item 4. Ownership. (a) and (b): As of the close of business on December 31, 2022, each of the Reporting Persons may have been deemed to have beneficial ownership of 145,000 shares of Common Stock held by Intracoastal, and all such shares of Common Stock in the aggregate represent beneficial ownership of approximately 6.2% of the Common Stock, based on 2,321,315 shares of Common Stock as of November 30, 2023, as reported by the Issuer. The foregoing excludes 290,000 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (“ Intracoastal Warrant 1 ”) because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial holder or any of the holder’s affiliates, of more than 4.99% of the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 435,000 shares of Common Stock. (c) Number of shares as to which each Reporting Person has: (i) Sole power to vote or to direct the vote: 0 . (ii) Shared power to vote or to direct the vote: 145,000 . (iii) Sole power to dispose or to direct the disposition of 0 . (iv) Shared power to dispose or to direct the disposition of 145,000 .

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. Page 5 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 6, 2024 /s/ Mitchell P. Kopin Mitchell P. Kopin /s/ Daniel B. Asher Daniel B. Asher Intracoastal Capital LLC By: /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager Page 6 of 6

View Full Filing

View this SC 13G/A filing on SEC EDGAR